GE HealthCare Technologies Inc. Q4 2024 Financial Highlights

In a remarkable financial disclosure on Thursday, GE HealthCare Technologies Inc. announced a 2.1% increase in its fourth-quarter revenue for the fiscal year 2024, totaling $5.3 billion. This growth is compared to the same period in the previous year. The company also reported a significant surge in net income and diluted earnings per share (EPS), both soaring by 78% year-on-year to $720 million and $1.57, respectively.

Full Year 2024 Performance and 2025 Outlook

Looking at the full fiscal year 2024, GE HealthCare achieved a 0.6% increase in total revenues, amounting to $19.7 billion. Net income saw a 27% rise to $1.9 billion, and diluted EPS experienced a 43% increase, reaching $4.34. For the upcoming year, the company anticipates adjusted EPS to be in the range of $4.61 to $4.75.

Leadership Insights

"We were pleased with the strong momentum in orders, backlog, and book-to-bill that we saw in the fourth quarter," stated President and CEO Peter Arduini. Despite the positive financial results, the company's shares saw a slight decrease of 1.05% in premarket trading, settling at $85.00 per share following the earnings report.